Medical device market penetration

FierceBiotech  Nov 19  Comment 
Federal regulators are proposing a rule that would require makers of drugs and medical devices to publicize the results of thousands of clinical trials, regardless of whether they succeed, part of a global move toward transparency in R&D.
MedPage Today  Nov 19  Comment 
(MedPage Today) -- Concern about the vulnerability of medical devices is growing.
Forbes  Nov 19  Comment 
Dr. David Albert, co-founder of AliveCor, is bucking a trend in IoT. Unlike smartwatches and health wearables that monitor the electrical energy from your heart, your electrocardiogram or ECG, his product is certified as a Class II medical device...
Forbes  Nov 13  Comment 
The push to repeal the Affordable Care Act’s tax on medical devices has somehow become a touchstone for GOP efforts to chip away at President Obama’s health care law. But why?  To paraphrase Bogart’s  classic line from Casablanca:  Of all...
Forbes  Nov 13  Comment 
Apparently, the medical device tax (MDT) is one of America’s biggest problems. Incoming Senate Majority Leader Mitch McConnell, R-Ky., has made its repeal one of his top priorities.
Wall Street Journal  Nov 11  Comment 
Parker Hannifin is making a push into medical devices with a set of motorized robotic braces that support and move the legs of people who can’t walk on their own, but it still needs to get the FDA and insurers on board.
Benzinga  Nov 10  Comment 
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain today announced that it has been granted...
Motley Fool  Nov 9  Comment 
Is Obamacare's path about to endure a major shift with Republicans taking control of Congress?
Motley Fool  Nov 8  Comment 
Medtronic and Stryker are among the medtech companies that may see profit climb if Congress moves to repeal the medical device tax.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki